Treatment of a life-threatening laryngeal bradykinin angio-oedema precipitated by dipeptidylpeptidase-4 inhibitor and angiotensin-I converting enzyme inhibitor with prothrombin complex concentrates

I. Millot1* D. Plancade1 M. Hosotte2 C. Landy1 J. Nadaud1 C. Ragot1 B. Graffin1 C. Drouet3 and G. Kanny2

首页> 外文期刊>British Journal of Anaesthesia >Treatment of a life-threatening laryngeal bradykinin angio-oedema precipitated by dipeptidylpeptidase-4 inhibitor and angiotensin-I converting enzyme inhibitor with prothrombin complex concentrates

【24h】

Treatment of a life-threatening laryngeal bradykinin angio-oedema precipitated by dipeptidylpeptidase-4 inhibitor and angiotensin-I converting enzyme inhibitor with prothrombin complex concentrates

机译：凝血酶原复合物浓缩物治疗二肽基肽酶-4抑制剂和血管紧张素I转化酶抑制剂沉淀的危及生命的喉缓激肽血管性水肿

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《British Journal of Anaesthesia》 |2012年第5期|p.827-829|共3页
作者
I. Millot1* D. Plancade1 M. Hosotte2 C. Landy1 J. Nadaud1 C. Ragot1 B. Graffin1 C. Drouet3 and G. Kanny2;
展开▼
作者单位

1Metz, France 2Nancy, France 3Grenoble, France;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Treatment of a life-threatening laryngeal bradykinin angio-oedema precipitated by dipeptidylpeptidase-4 inhibitor and angiotensin-I converting enzyme inhibitor with prothrombin complex concentrates [J] . MillotI., PlancadeD., HosotteM., British journal of anaesthesia . 2012,第5期

机译：凝血酶原复合物浓缩物治疗由二肽基肽酶-4抑制剂和血管紧张素I转化酶抑制剂沉淀的危及生命的喉缓激肽血管性水肿
2. Protein kinase C and phosphatase inhibitors block the ability of angiotensin I-converting enzyme inhibitors to resensitize the receptor to bradykinin without altering the primary effects of bradykinin. [J] . Marcic BM, Erdos EG The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics . 2000,第2期

机译：蛋白激酶C和磷酸酶抑制剂可阻止血管紧张素I转换酶抑制剂重新使受体对缓激肽敏感，而不会改变缓激肽的主要作用。
3. Mortality in patients with hypertension on angiotensin-I converting enzyme (ACE)-inhibitor treatment is influenced by the ACE insertion/deletion polymorphism. [J] . Bleumink GS, Schut AF, Sturkenboom MC, Pharmacogenetics and genomics . 2005,第2期

机译：血管紧张素-I转换酶（ACE）抑制剂治疗对高血压患者的死亡率受ACE插入/缺失多态性的影响。
4. AN NMR STUDY OF THE INTERACTION BETWEEN BRADYKININ AND ANGIOTENSIN-I AND SYNTHETIC PEPTD3E-BASED ANGIOTENSIN-I CONVERTING ENZYME CATALYTIC SITE MAQUETTES (CSM) [C] . Athanassios S. Galanis, Zinovia Spyranti, Natalia Tsami the European Peptide Symposium . 2007

机译：Bradykinin和血管紧张素-I和合成PEPTD3E基血管紧张素-I转化酶催化点MAQUETTES（CSM）相互作用的NMR研究
5. Potentiation of bradykinin actions by angiotensin I converting enzyme inhibitors. [D] . Minshall, Richard Dale. 1997

机译：血管紧张素Ⅰ转化酶抑制剂增强缓激肽作用。
6. Four-factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors versus Warfarin in Life-threatening Bleeding [O] . Megan A. Rech, Dalila Masic, Drayton A. Hammond 2021

机译：四因素凝血酶浓缩浓缩物用于逆转因子XA抑制剂与Warfarin威胁的出血
7. Life-threatening ACE inhibitor-induced angio-oedema successfully treated with icatibant:a bradykinin receptor antagonist [O] . Ostenfeld, Sarah, Bygum, Anette, Rasmussen, Eva Rye 2015

机译：依卡替班：缓激肽受体拮抗剂成功治疗威胁生命的ACE抑制剂引起的血管性水肿
8. Soluble Dextran Complexes of Kallikrein, Bradykinin and Enzyme Inhibitors. [R] . Odya, C. E., Levin, Y., Erdoes, E. G., 1977

机译：激肽释放酶，缓激肽和酶抑制剂的可溶性葡聚糖复合物。

Treatment of a life-threatening laryngeal bradykinin angio-oedema precipitated by dipeptidylpeptidase-4 inhibitor and angiotensin-I converting enzyme inhibitor with prothrombin complex concentrates

著录项

相似文献

相关主题

期刊订阅